Prevalence of abnormal Pap smear in pregnant women attending the antenatal clinic in Dr S N Medical college and attached hospitals, Jodhpur

Dr Rizwana Shaheen, Dr Shruti Paliwal, Dr Anita Bakoliya


Background: Worldwide carcinoma cervix is the most common cancer after carcinoma breast.Most cervical cancers are preventable.1 in 100 women will develop cervical cancer by age of 75.PAP smear being most sensitive and specific screening test reducing mortality and morbidity, can be used to identify early changes in cervix during pregnancy.


Aims & objective: 1) To detect abnormal pap’s smear in pregnant patients. 2) To study the epidemiological profile. 3) To identify the risk factors.

Material & Methods: A cross-sectional study involving patients attending OPD for regular antenatal check-up was carried out in antenatal clinic of Dr S N Medical College and attached hospitals, Jodhpur during time duration October 2015-March 2016.The data was obtained using a questionnaire.Conventional Pap smears were taken. The cytological results were reported based on the Bethesda classification system 2001.


Results: Total 200 women participated in the study. 6 patients out of 200 were found to have abnormal Pap smear. Prevalence of abnormal Pap smear was 3%. Maximum number of patients with cervical dysplasia belonged to age group 30-35 years, with low socio-economic status, low level of education, women who had sexual intercourse before 20 years, and in multiparous women.


Prevalence, abnormal Pap smear, pregnant women, carcinoma cervix, Bathesda classification

Full Text:



Arbyn M, Autier P, Ferlay J. Burden of cervical cancer in the 27 member states of the European Union: estimates for 2004. Ann Oncol. 2007;18(8):1423-5.

Womack C, Warren AY. Achievable laboratory standards; a review of cytology of 99 women with cervical cancer. Cytopathology 1998;9:171-7.

Ingprasarn A, et al.Prevalence of Abnormal Conventional Pap Smear in Pregnant Women.Thai Journal of Obstetrics and Gynaecology July 2014, Vol. 22, pp. 137-142

Morimura Y, Fujimori K, Soeda S. Cervical cytology during pregnancy-a comparison with non-pregnant women and management of women with abnormal cytology. Fukushima J Med Sci 2001;48:27-37.

Singh N. HPV and Cervical cancer – prospects for prevention through vaccination. Indian J Med Paediatr Oncol. 2005;26:20-3.

Economos K, Perez Veridiano N, Delke I et al. Abnormal cervical cytology in pregnancy : a 17 –year experience. Obstet Gynecol 1993 ; 81: 915-8.

Manikkam B. Screening for cervical cancer during pregnancy. Int J Community Med Public Health 2016;3:2493-8.

Vural E, Gonenc L, Aka N. Antenatal kontrollerde pap smear taraması ve Sonucları. Türkiye Aile Hekimligi Dergisi. 2004;8:111-5.

Dinc A. Pap Smear Screening Results for Turkish Pregnant Women. Asian Pacific Journal of Cancer Prevention. 2012;13(11):5835-8.

Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study Mari Nygård1*, Anne-Kjersti Daltveit, Steinar Ø Thoresen1 and Jan F Nygård1 BMC Health Services Research 2007, 7:10 doi:10.1186/1472-6963-7-10.

Selleret Land Mathevet P (2008). Precancerous cervical lesions during pregnancy: diagnostic and treatment. J Gynecol Obstet Biol Reprod, 37, 131-8.

Apgar BS, Kittendorf AL, Bettcher CM, Wong J, Kaufman AJ. Update On ASCCP Consensus Guidelines for Abnormal Cervical Screening Tests and Cervical Histology. Am Fam Physician. 2009;80(2):147-55.

Ueki M, Ueda M, Kumagai K, Okamoto Y, Noda S, Matsuoka M. Cervical Cytology And Conservative Management Of Cervical Neoplasias During Pregnancy. J Low Genit Tract Dis. 2009;13(3):182-5.

Connor JP. Noninvasive cervical cancer complicating pregnancy. Obstet Gynecol Clin North Am 1998; 25: 331-42

Huff BC. Abnormal cervical cytology in pregnancy: A laboratory and clinical dermatologic perspective. J Perinat Neonatal Nurs 2000; 14: 52-62.


  • There are currently no refbacks.